发明授权
US08354416B2 7,8-dihydropyrido[2,3-d]pyrimidin-4-yl substituted compounds as inhibitors of p38 kinase
失效
7,8-二氢吡啶并[2,3-d]嘧啶-4-基取代的化合物作为p38激酶的抑制剂
- 专利标题: 7,8-dihydropyrido[2,3-d]pyrimidin-4-yl substituted compounds as inhibitors of p38 kinase
- 专利标题(中): 7,8-二氢吡啶并[2,3-d]嘧啶-4-基取代的化合物作为p38激酶的抑制剂
-
申请号: US12132793申请日: 2008-06-04
-
公开(公告)号: US08354416B2公开(公告)日: 2013-01-15
- 发明人: James F. Callahan , Jeffrey C. Boehm , Anthony William James Cooper , Stefano Livia , Paul Bamborough , Neysa Nevins , Zehong Wan , Beth A. Norton , Xichen Lin
- 申请人: James F. Callahan , Jeffrey C. Boehm , Anthony William James Cooper , Stefano Livia , Paul Bamborough , Neysa Nevins , Zehong Wan , Beth A. Norton , Xichen Lin
- 申请人地址: GB Greenford, Middlesex
- 专利权人: Glaxo Group Limited
- 当前专利权人: Glaxo Group Limited
- 当前专利权人地址: GB Greenford, Middlesex
- 代理商 James P. Riek
- 主分类号: C07D471/04
- IPC分类号: C07D471/04 ; A61K31/519 ; A61P29/00 ; A61P9/10
摘要:
Novel substituted 2,4,8-trisubstituted 8H-pyrido[2,3-d]pyrimidin-7-one containing compounds and compositions, and their use in therapy as CSBP/RK/p38 kinase inhibitors.
公开/授权文献
- US20090156597A1 Novel Compounds 公开/授权日:2009-06-18
信息查询